Nanogen, Deltagen, Lynx, Northeastern University, Third Wave, EraGen, LightUp Technologies | GenomeWeb

Nanogen Sacks 20 Percent of Staff As Focus on Molecular Dx Intensifies

Nanogen has laid off around 20 percent of its staff as it takes steps to better manage resources dedicated to developing and marketing molecular diagnostics, the company said last week.

The reduction in staff, which brings total headcount to 156, is expected to save Nanogen around $5 million this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.